Suppliers / Eisai Manufacturing

Eisai Manufacturing

United Kingdom 630 employees 2 duplicate records merged Updated 9 July 2026

Eisai Manufacturing is a finished-dose manufacturer based in United Kingdom. It appears in 81 regulatory filings across 10 regulators, without an active US DMF or CEP on file. Its filings concentrate with ANVISA (Brazil), US FDA and EDE (AE). Its GMP standing is certified by MHRA (UK), ANVISA (Brazil) and US FDA, among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 9 April 2024 as VAI.

0
active US DMFs
0
valid CEPs
10
registered plants 5 with an FDA FEI number
81
filings across 10 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
5 of 5 confirmed
Inspections
8 of 8 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 9 April 2024 VAI US FDA
  • 27 October 2023 VAI US FDA
  • 18 November 2022 VAI US FDA
  • 21 January 2022 VAI US FDA
  • 1 February 2019 VAI US FDA
  • 21 December 2018 VAI US FDA
  • 29 November 2018 VAI US FDA
  • 15 September 2017 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Hatfield, United Arab Emirates Not on file
São Paulo, Brazil Not on file
SAO PAULO, Brazil Not on file
HATFIELD, United Kingdom Not on file
United Kingdom, United Kingdom 3008356774
Japan, Japan 3002806886

4 further sites are on record.

Filings and GMP by regulator

Regulator Filings GMP certificates
ANVISA (Brazil) 18 3
US FDA 15 2
EDE (AE) 13 None
SAHPRA (ZA) 11 None
CDSCO (India) 9 None
NPRA (MY) 5 None
MHRA (UK) None 4
MFDS (Korea) None 2
EMA None 1

Comparing suppliers?

Choose your molecules and target markets. Eisai Manufacturing comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 9 April 2024.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates